Food & Drug Administration issues new warning on rare autoimmune disorder linked to J&J coronavirus vaccine
On Monday, the U.S. Food and Drug Administration (“FDA”) warned of an increased risk of Guillain-Barre, a rare neurological disorder, following the Johnson & Johnson vaccine after 100 preliminary cases of the syndrome were reported among the